Table 1 Baseline characteristics of patients.
Characteristic | Overall (n = 77) | Complete occlusion group (n = 53) | Persistence group (n = 24) | P-value |
|---|---|---|---|---|
Age, median (IQR), year | 53 (47–58) | 53 (47–58) | 53 (47–58) | 0.978 |
Sex, male, n (%) | 61 (79.2) | 41 (77.4) | 20 (83.3) | 0.549 |
Smoking, n (%) | 26 (33.8) | 17 (32.1) | 9 (37.5) | 0.641 |
Hypertension, n (%) | 42 (54.5) | 33 (62.3) | 9 (37.5) | 0.043 |
Hyperlipidemia, n (%) | 21 (27.3) | 16 (30.2) | 5 (20.8) | 0.393 |
Diabetes mellitus, n (%) | 10 (13.0) | 6 (11.3) | 4 (16.7) | 0.493 |
Coronary artery disease, n (%) | 3 (3.9) | 3 (5.7) | 0 (0.0) | 0.548 |
Pre-procedural mRS > 2, n (%) | 3 (3.9) | 3 (5.7) | 0 (0.0) | 0.548 |
Dominant VA, n (%)* | 54 (70.1) | 37 (69.8) | 17 (70.8) | 0.877 |
Significant stenosis, n (%) | 9 (13.0) | 3 (7.5) | 6 (25.0) | 0.023 |
BA involvement, n (%) | 3 (3.9) | 1 (1.9) | 2 (8.3) | 0.228 |
Entirely involved circumference, n (%) | 40 (51.9) | 25 (47.2) | 15 (62.5) | 0.212 |
PICA involvement, n (%) | 18 (23.4) | 9 (17.0) | 9 (37.5) | 0.049 |
Maximum diameter, median (IQR), mm | 10.8 (9.0–14.6) | 11.1 (9.0–14.6) | 9.9 (8.9–14.7) | 0.708 |
